HI
Humankind Investments LLC
13F filer · CIK 0001845373Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$209MU.S. long equity reported on 13F
Positions173 new · 0 closed
Net flow last quarter+$751KBuys minus sells
Top 10 positions weight65.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202617 positions | |||||
| $37.3M | 17.85% | Not reported | Not reported | Q4 2020 | |
| $23.3M | 11.13% | Not reported | Not reported | Q4 2020 | |
| $19.1M | 9.12% | 0.00% | Not reported | Q4 2020 | |
| $16.4M | 7.86% | 0.00% | Not reported | Q4 2020 | |
| $9.85M | 4.71% | 0.00% | Not reported | Q4 2020 | |
| $7.72M | 3.69% | 0.02% | Not reported | Q1 2026 | |
| $6.92M | 3.31% | Not reported | Not reported | Q1 2026 | |
| $5.76M | 2.76% | 0.00% | Not reported | Q1 2021 | |
| $5.08M | 2.43% | 0.00% | Not reported | Q1 2021 | |
| $4.46M | 2.13% | 0.01% | Not reported | Q1 2026 | |
| $4.06M | 1.94% | 0.00% | Not reported | Q4 2020 | |
| ATAPGEApogee Therapeutics, Inc. | $2.32M | 1.11% | 0.02% | Not reported | Q1 2026 |
| $1.44M | 0.69% | 0.01% | Not reported | Q1 2026 | |
| $1.13M | 0.54% | 0.01% | Not reported | Q1 2026 | |
| $302K | 0.14% | 0.00% | New | Q2 2026 | |
| $225K | 0.11% | 0.00% | New | Q2 2026 | |
| $224K | 0.11% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported May 15, 202614 positions | |||||
| $29.3M | 16.71% | Not reported | -41.4% | Q4 2020 | |
| $20.3M | 11.58% | Not reported | -47.3% | Q4 2020 | |
| $18.9M | 10.80% | 0.00% | +98.1% | Q4 2020 | |
| $14.4M | 8.23% | 0.00% | Not reported | Q4 2020 | |
| $8.91M | 5.09% | 0.02% | New | Q1 2026 | |
| $6.51M | 3.72% | 0.00% | Not reported | Q4 2020 | |
| $6.43M | 3.67% | Not reported | New | Q1 2026 | |
| $6.07M | 3.46% | 0.00% | Not reported | Q1 2021 | |
| $5.92M | 3.38% | 0.00% | Not reported | Q1 2021 | |
| $4.19M | 2.39% | 0.00% | Not reported | Q4 2020 | |
| $3.96M | 2.26% | 0.01% | New | Q1 2026 | |
| ATAPGEApogee Therapeutics, Inc. | $1.47M | 0.84% | 0.02% | New | Q1 2026 |
| $1.14M | 0.65% | 0.01% | New | Q1 2026 | |
| $1.12M | 0.64% | 0.01% | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 20267 positions | |||||
| $53.2M | 23.85% | Not reported | Not reported | Q4 2020 | |
| $40.3M | 18.09% | Not reported | Not reported | Q4 2020 | |
| $15.9M | 7.11% | 0.01% | Not reported | Q4 2023 | |
| $15.4M | 6.93% | 0.00% | -27.7% | Q4 2020 | |
| $12.5M | 5.60% | 0.00% | -20.7% | Q4 2020 | |
| $6.46M | 2.90% | 0.00% | -5.9% | Q4 2020 | |
| $5.18M | 2.32% | 0.00% | +24.7% | Q4 2020 | |
| Q3 2025Reported Nov 14, 2025140 positions | |||||
| $52M | 11.90% | Not reported | Not reported | Q4 2020 | |
| $39.4M | 9.02% | Not reported | Not reported | Q4 2020 | |
| $20M | 4.58% | 0.00% | -0.9% | Q4 2020 | |
| $16.9M | 3.86% | 0.00% | -2.3% | Q4 2020 | |
| $14.2M | 3.26% | 0.01% | Not reported | Q4 2023 | |
| $7.46M | 1.71% | 0.00% | -15.2% | Q4 2020 | |
| $6.1M | 1.40% | 0.00% | 0.0% | Q4 2020 | |
| $5.2M | 1.19% | 0.02% | -12.3% | Q3 2021 | |
| $4.67M | 1.07% | 0.00% | -19.8% | Q4 2020 | |
| $3.89M | 0.89% | 0.00% | -7.2% | Q1 2021 | |
| $3.78M | 0.87% | 0.00% | +13.1% | Q1 2021 | |
| $3.64M | 0.83% | 0.00% | -10.1% | Q4 2020 | |
| $3.48M | 0.80% | 0.00% | -11.0% | Q1 2021 | |
| $3.37M | 0.77% | 0.02% | +2.7% | Q1 2021 | |
| $2.7M | 0.62% | 0.00% | +9.9% | Q1 2021 | |
| $2.43M | 0.56% | 0.00% | +13.4% | Q1 2021 | |
| $2.42M | 0.55% | 0.00% | -5.3% | Q1 2021 | |
| $2.41M | 0.55% | 0.00% | +7.0% | Q2 2021 | |
| $2.19M | 0.50% | 0.00% | -5.8% | Q1 2021 | |
| $2.18M | 0.50% | 0.01% | +3.8% | Q1 2023 | |
| $2.16M | 0.50% | 0.00% | -6.7% | Q1 2021 | |
| $2.11M | 0.48% | 0.02% | +13.4% | Q1 2021 | |
| $1.95M | 0.45% | 0.00% | +7.8% | Q1 2021 | |
| $1.85M | 0.42% | 0.00% | -12.4% | Q4 2020 | |
| $1.65M | 0.38% | 0.01% | -3.6% | Q2 2024 | |
| $1.62M | 0.37% | 0.00% | -5.8% | Q1 2021 | |
| $1.61M | 0.37% | 0.00% | -3.6% | Q1 2021 | |
| $1.53M | 0.35% | 0.00% | +0.5% | Q1 2021 | |
| $1.51M | 0.35% | 0.01% | +36.6% | Q1 2021 | |
| $1.48M | 0.34% | 0.00% | +0.8% | Q1 2021 | |
| $1.46M | 0.33% | 0.00% | -4.2% | Q1 2021 | |
| $1.42M | 0.32% | 0.00% | -9.8% | Q1 2021 | |
| $1.39M | 0.32% | 0.00% | +3.9% | Q1 2021 | |
| $1.3M | 0.30% | 0.00% | +7.8% | Q2 2021 | |
| $1.26M | 0.29% | 0.00% | -0.1% | Q1 2021 | |
| $1.23M | 0.28% | 0.01% | +3.8% | Q1 2021 | |
| $1.23M | 0.28% | 0.00% | -13.8% | Q1 2021 | |
| $1.23M | 0.28% | 0.00% | -6.4% | Q1 2021 | |
| $1.2M | 0.28% | 0.00% | +3.5% | Q1 2021 | |
| $1.16M | 0.26% | 0.00% | +12.2% | Q1 2021 | |
| $1.12M | 0.26% | 0.00% | +15.1% | Q2 2021 | |
| $1.1M | 0.25% | 0.01% | +5.6% | Q1 2021 | |
| $1.1M | 0.25% | 0.00% | -3.6% | Q4 2020 | |
| $1.07M | 0.24% | 0.00% | +10.9% | Q1 2021 | |
| $1.05M | 0.24% | 0.01% | +16.3% | Q2 2023 | |
| $1.04M | 0.24% | 0.00% | +14.7% | Q1 2021 | |
| $973K | 0.22% | 0.00% | -8.4% | Q1 2021 | |
| $921K | 0.21% | 0.00% | -3.4% | Q2 2021 | |
| $881K | 0.20% | 0.00% | -0.8% | Q2 2021 | |
| $858K | 0.20% | 0.00% | +10.9% | Q1 2021 | |
Premium opens every quarter this fund has filed